The Inflation Reduction Act includes an exemption for orphan drugs for a single indication, but experts say this is far from ...

Detailed price information for Alnylam Pharmaceuticals (ALNY-Q) from The Globe and Mail including charting and trades.

The approach could enable 30-minute testing for a heart condition that is newly treatable following recent drug approvals.

Alnylam Pharmaceuticals (NasdaqGS:ALNY) recently announced the appointment of Dr. Pushkal Garg as Executive Vice President and Chief Research and Development Officer to accelerate its R&D efforts.

Alnylam Pharmaceuticals named Pushkal Garg executive vice president and chief research and development officer. The company said Wednesday that Garg will help oversee an integrated R&D organization to ...

Issi covers the Healthcare sector, focusing on stocks such as Alnylam Pharma, Ultragenyx Pharmaceutical, and Ascendis Pharma. In addition to RBC Capital, Alnylam Pharma also received a Buy from J.P.

GlobalData estimates that vutrisiran’s entrance into the ATTR-wt market will change the treatment paradigm.

Ratings for Alnylam Pharmaceuticals ALNY -1.28% Get Free Report were provided by 18 analysts in the past three months, ...

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) is one of the 13 Biotech Stocks with Huge Upside Potential. It declared on June 9, 2025, that AMVUTTRA® (vutrisiran) has been approved by the European ...